Keeping abreast of changing payment models and regulations is key to maximizing your practice's finances.
Katherine A. Roberts, MD, FACE, ECNU, discusses her experience with opting out of Medicare and offers advice to physicians considering doing the same.
A lack of insurance coverage for weight-loss treatments as well as diagnoses of obesity are significant barriers.
A study suggests that female physicians do not use as many codes as their male counterparts, resulting in a reimbursement gap.
Changes have been proposed to the Physician Fee Schedule to transform how Medicare pays for primary care, focusing on improvements in pay for care coordination and planning.
Health insurance premiums under the Affordable Care Act will rise in 2017, analysts and insurance brokers said.
First full year of Medicare Shared Savings Program contracts is linked to an early drop in Medicare spending.
Compiling the information needed to approach insurance companies is time consuming.
Simplification, consolidation, and real time point-of-care information could address the inefficiencies in the medical billing system.
Tips for increasing patient adherence to treatment plans include patient engagement and addressing barriers to adherence, according to an article published in Medical Economics.
Demand for medical office space for ambulatory care is at a high point and looks likely to continue increasing, according to an article published in Forbes.
In order to prevent denials, it is important to code correctly within the International Classification of Diseases, Tenth Revision (ICD-10), with specificity matching documentation, according to an article published in Medical Economics.
Pay-for-performance measures have an overall positive effect on disease management, according to new data.
Plans will include low copay for specialist visits related to diabetes, free supplies, and financial incentives.
Although Medicaid expansion does not work for many doctors, states are trying to find ways to make it work.
Suggestions include price controls on drugs, hospitals, and doctors.
Health insurance often excludes obesity treatments, even when target BMI is included in employee wellness programs.
Pros include fostering of therapeutic relationship, while cons include lack of evidence for benefits.
Although ICD-10 will allow greater specificity and clinical accuracy in noting procedures and diagnoses, the transition presents challenges.
One in five workers now have a deductible of $2,000 or more.
Importance of understanding costs due to ACA, prevalence of high-deductible plans.
Primary care providers mostly positive about impact of health information technology but are divided on ACOs.
Physicians must be able to balance provision of good clinical care with ability to limit costs.
Physicians often unaware of revenue lost to virtual credit cards, and the AMA is advocating for more transparency.
Tips to implement include verification of insurance status, collection at time of service and ease of payment.
Intake forms should remind patients of their responsibility for paying bills and collection costs.
Total adjusted per-beneficiary spending down in ACO group vs. control group.
Legislation includes provisions such as simplification of reporting programs and incentive payments.
Tips to ease transition include contacting vendors and health plans and improving documentation.
California and New York fully expanded Medicaid coverage under ACA, but Texas and Florida did not.
Endocrinology Advisor Articles
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Incidence of Diabetes Influenced by Endocrine-Disrupting Chemicals in the Environment
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Type 2 Diabetes and Alzheimer Disease: What's the Connection?
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- New Romosozumab BLA Includes Data from Additional Osteoporosis Trials
- Impact of Maternal Diabetes on Outcomes in Very Preterm, Very Low-Birth-Weight Infants
- Age-Related Differences in Manifestation of Cushing Disease Identified